Login/Register for the Webcast

Speakers

Dr Durhane Wong-Rieger

PhD, President & CEO Canadian Organization for Rare Disorders,
Toronto, ON, Canada

Prof Luca Pani

MD, University of Modena and Reggio Emilia, Italy
University of Miami, USA

Dr Jens Grueger

PhD, Partner Boston Consulting Group
Fellow at the BCG Henderson Institute
Affiliate Professor of Health Economics at the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at University of Washington

Dr Ain Aaviksoo

MD MPH, Chief Medical Officer, Guardtime, HeBA Clinic and TalTech, Tallinn, Estonia

Dr Amanda Cole

PhD, Senior Principal Economist, Office of Health Economics, UK

Prof Graham Cookson

PhD, Chief Executive, Office of Health Economics, UK
Honorary Visiting Professor in Economics at City, University of London

In this free two-hour Masterclass delegates will:

Be presented with a multi-stakeholder view on the need for and opportunities associated with payment models that recognise value at the indication-level, leveraging the findings of the OHE Consensus Programme and the experience of international experts.
Explore insights and learnings: what are the various implementation models, and what can we learn from experience with them to date?
Have a forum for questions, answers, and sharing of information amongst participants.

View Agenda

This Masterclass is intended to be useful for a wide range of stakeholders that are interested in payment models for multi-indication therapies, including (but not limited to) payers, PAGs, regulators, health data scientists, academics and industry. In order to register for the event, delegates are required to reside in one of the countries listed in the relevant drop-down menu on the registration page. The event will be recorded. This is an AstraZeneca organised and funded non-promotional meeting facilitated by OHE.

Veeva ID No.: Z4-44423 Date of Prep: May 2022

Collaborating on payment models to unlock the potential of multi-indication therapies

Add to your calendar